{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:32:17Z","timestamp":1794429137758,"version":"4.9.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Chimeric antigen receptor\u2013engineered NK-92 (CAR-NK-92) cells emulate activated natural killer cells, combining potent innate cytotoxicity with CAR-driven antigen specificity. Their scalability and FDA approval make them attractive for universal use. However, their application in solid tumors remains limited by the immunosuppressive tumor microenvironment (TME), which is often characterized by hypoxia and nutrient deprivation. We recently demonstrated that an ATF4-inducible promoter, 2xAARE-YB, enables spatial and temporal control of CAR expression in T cells, enhancing safety by restricting expression to amino acid-deprived TME while reducing exhaustion to improve persistence. In this study, we adapted the 2xAARE-YB system for CAR-NK-92 cells. Under glucose-limited conditions, a hallmark of the TME, the system effectively regulated CAR expression, enabling potent antigen-specific cytotoxicity. In xenograft models, the nutrient-responsive 2xAARE-YB system achieved regulated intratumoral CAR expression\n                    <jats:italic>in vivo<\/jats:italic>\n                    , supporting its potential for the development of safer therapeutic strategies. Additionally, the clinically approved ER stress\u2013inducing drug artesunate also reliably activated the circuit, offering a drug-inducible regulation of CAR expression. Collectively, these findings establish 2xAARE-YB as a dual-mode regulatory platform that enables tunable, context-dependent CAR expression in NK-92 cells. Although this approach may be more effective in HLA I-negative tumors than in HLA I-positive tumors, it represents a promising path toward safer and more adaptable CAR-NK-92 therapies tailored for the dynamic metabolic constraints of solid tumors.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1792164","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:56:59Z","timestamp":1772693819000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Tunable CAR-NK-92 activity in the tumor microenvironment via a dual ATF4-responsive circuit"],"prefix":"10.3389","volume":"17","author":[{"given":"Enzo","family":"Manchon","sequence":"first","affiliation":[{"name":"National Institute of Health and Medical Research (INSERM) UMR 1342, Paris University, Saint-Louis Hospital","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nell","family":"Hirt","sequence":"additional","affiliation":[{"name":"National Institute of Health and Medical Research (INSERM) UMR 1342, Paris University, Saint-Louis Hospital","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravindhan","family":"Soundiramourty","sequence":"additional","affiliation":[{"name":"Asfalia Biologics, Paris Brain Institute (ICM), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Versier","sequence":"additional","affiliation":[{"name":"Asfalia Biologics, Paris Brain Institute (ICM), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Christen","sequence":"additional","affiliation":[{"name":"Asfalia Biologics, Paris Brain Institute (ICM), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Charron","sequence":"additional","affiliation":[{"name":"National Institute of Health and Medical Research (INSERM) UMR 1342, Paris University, Saint-Louis Hospital","place":["Paris, France"]},{"name":"Asfalia Biologics, Paris Brain Institute (ICM), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Mallet","sequence":"additional","affiliation":[{"name":"Asfalia Biologics, Paris Brain Institute (ICM), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Jabrane-Ferrat","sequence":"additional","affiliation":[{"name":"Institute for Infectious and Inflammatory Diseases, National Center of Scientific Reserach (CNRS) UMR5051, Institute of Health and Medical Research (INSERM) UMR1291, Toulouse University","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che","family":"Serguera","sequence":"additional","affiliation":[{"name":"Asfalia Biologics, Paris Brain Institute (ICM), H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Al-Daccak","sequence":"additional","affiliation":[{"name":"National Institute of Health and Medical Research (INSERM) UMR 1342, Paris University, Saint-Louis Hospital","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41420-024-02077-1","article-title":"Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions","volume":"10","author":"Zhong","year":"2024","journal-title":"Cell Death Discov"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.06.025","article-title":"The next generation of cellular immunotherapy: chimeric antigen receptor-natural killer cells","volume":"28","author":"Moscarelli","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.732135","article-title":"Current perspectives on \u201cOff-the-shelf\u201d Allogeneic NK and CAR-NK cell therapies","volume":"12","author":"Heipertz","year":"2021","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"114145","DOI":"10.1016\/j.celrep.2024.114145","article-title":"Precision off-the-shelf natural killer cell therapies for oncology with logic-gated gene circuits","volume":"43","author":"Frankel","year":"2024","journal-title":"Cell Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"ltac003","DOI":"10.1093\/immadv\/ltac003","article-title":"Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy","volume":"2","author":"Schmidt","year":"2022","journal-title":"Immunother Adv"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01145-x","article-title":"Development of NK cell-based cancer immunotherapies through receptor engineering","volume":"21","author":"Page","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040992","article-title":"Hypoxia-driven immune escape in the tumor microenvironment","volume":"9","author":"Vito","year":"2020","journal-title":"Cells."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01290-x","article-title":"Harnessing nutrient scarcity for enhanced CAR-T-cell potency and safety in solid tumors","volume":"22","author":"Manchon","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/88115","article-title":"The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain","volume":"19","author":"Zennou","year":"2001","journal-title":"Nat Biotechnol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00655.x","article-title":"A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria","volume":"45","author":"Batty","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3582","article-title":"Regulating the expression of therapeutic transgenes by controlled intake of dietary essential amino acids","volume":"34","author":"Chaveroux","year":"2016","journal-title":"Nat Biotechnol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00262-022-03299-x","article-title":"Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy","volume":"72","author":"Beelen","year":"2023","journal-title":"Cancer Immunol Immunother."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-007-0411-3","article-title":"Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines","volume":"57","author":"Mendez","year":"2008","journal-title":"Cancer Immunol Immunother."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124307","article-title":"Characterization of HLA-G regulation and HLA expression in breast cancer and Malignant melanoma cell lines upon IFN-gamma stimulation and inhibition of DNA methylation","volume":"21","author":"Jorgensen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s42003-021-01664-7","article-title":"Synthetic promoters to induce immune-effectors into the tumor microenvironment","volume":"4","author":"Greenshpan","year":"2021","journal-title":"Commun Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7150\/thno.58390","article-title":"Turning cold tumors into hot tumors by improving T-cell infiltration","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0139-2","article-title":"Immunometabolism and natural killer cell responses","volume":"19","author":"O\u2019Brien","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell."},{"key":"B19","doi-asserted-by":"publisher","first-page":"100227","DOI":"10.1016\/j.xcrm.2021.100227","article-title":"Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors","volume":"2","author":"Kosti","year":"2021","journal-title":"Cell Rep Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00191.2015","article-title":"Physiologic hypoxia and oxygen homeostasis in the healthy intestine. A Review in the Theme: Cellular Responses to Hypoxia","volume":"309","author":"Zheng","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/01.WCB.0000081369.51727.6F","article-title":"Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis","volume":"23","author":"Chih","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02683","article-title":"CAR-engineered NK cells for the treatment of glioblastoma: turning innate effectors into precision tools for cancer immunotherapy","volume":"10","author":"Burger","year":"2019","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1618446114","article-title":"In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors","volume":"114","author":"Torcellan","year":"2017","journal-title":"Proc Natl Acad Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1792164\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:57:00Z","timestamp":1772693820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1792164\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2026.1792164"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1792164","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1792164.s001","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"article-number":"1792164"}}